Muscle Mass or Muscle Function as a prédictive Tools for Outtcomme in Chronic Dialysis Patients

Chrnoic Haemodialysis Patients Clinical Trial

Official title:

Retrospective Study : Muscle Mass or Muscle Function as a prédictive Tools for Outtcomme in Chronic Dialysis Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03845452
• Other study ID #: RECHMPL18_0447
• Status: Completed
• Start date: January 1, 2016
• Est. completion date: January 31, 2019

Study information

• Verified date: February 2019
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Aim of this study is to compare the association of muscle mass and functionality with mortality among chronic haemodialysis

• the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C reactive protein and decrease in serum albumin) on voluntary muscle strength impairment and phyiscal activity.

• the relationship between voluntary muscle strength and mortality

• the relationship between voluntary muscle strength and physical activity

Description:

Aim of this study is to compare the association of muscle mass and functionality with mortality among chronic haemodialysis

• the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C reactive protein and decrease in serum albumin) on voluntary muscle strength impairment and phyiscal activity.

• the relationship between voluntary muscle strength and mortality

• the relationship between voluntary muscle strength and physical activity

Recruitment information / eligibility

• Status: Completed
• Enrollment: 187
• Est. completion date: January 31, 2019
• Est. primary completion date: January 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion criteria:

• chronic kidney disease patient with extrarenal replacement therapy by hemodialysis for at least 3 months

• stable clinical condition (absence of infection, stroke or acute decompensation)

Exclusion criteria:

• chronic kidney disease without extrarenal replacement therapy

• history of renal transplantation

Related Conditions & MeSH terms

• Chrnoic Haemodialysis Patients

Locations

Country	Name	City	State
France	Uhmontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality at 2 years	Mortality at 2 years	2 years